Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faecium

Diagn Microbiol Infect Dis. 2018 Jun;91(2):161-163. doi: 10.1016/j.diagmicrobio.2018.01.027. Epub 2018 Feb 3.

Abstract

We assessed risk factors for and outcomes of linezolid-resistant vancomycin-resistant Enterococcus faecium (LRVREF) bacteremia over 7 years. Thirty-four LRVREF cases were matched to 68 linezolid-susceptible VREF controls. The odds of bacteremia with LRVREF increased by 7% for each additional day of prior linezolid exposure.

Keywords: Enterococcus faecium; Linezolid-resistant enterococci; VRE.

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Drug Resistance, Multiple, Bacterial / drug effects*
  • Enterococcus faecium / drug effects*
  • Female
  • Gram-Positive Bacterial Infections / drug therapy
  • Gram-Positive Bacterial Infections / microbiology*
  • Humans
  • Linezolid / pharmacology*
  • Linezolid / therapeutic use
  • Male
  • Middle Aged
  • Retrospective Studies
  • Time Factors
  • Vancomycin-Resistant Enterococci / drug effects*

Substances

  • Anti-Bacterial Agents
  • Linezolid